---
id: d980569351
section: business
first_reported: 2026-11-13 18:15 EST
updated: 2026-11-13 18:15 EST
status: reported
outlets: 1
---

# Boston biotech Rezera delays $200 million IPO

Rezera postponed its $200 million initial public offering, citing market conditions, according to The Boston Globe.

Section: [Business & Economy](/boston/section/business.md) · Entities: [Rezera](/boston/wiki/rezera.md)

## Coverage

- [The Boston Globe](https://www.bostonglobe.com/2026/11/13/business/rezera-biotech-ipo-delay/), 2026-11-13 18:15 EST: Boston biotech Rezera delays $200 million IPO

Headline and summary written by the Acta Diurna desk from the coverage above. Read the original reporting for full detail.